Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced Dedifferentiated Liposarcoma · Advanced Leiomyosarcoma · Advanced Soft Tissue Sarcoma · Metastatic Dedifferentiated Liposarcoma · Metastatic Leiomyosarcoma · Metastatic Soft Tissue Sarcoma · Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 · Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • M D Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 877-632-6789
    Contact: Principal Investigator (Elise F. Nassif)
Study leads
  • Elise F Nassif

    Principal Investigator

    University of Texas MD Anderson Cancer Center LAO